NOT-CA-22-073: Notice of Correction to RFA-CA-22-013, "PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)"

Notice of Correction to RFA-CA-22-013, "PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)"

Notice Number:

NOT-CA-22-073

Key Dates

Release Date:

April 4, 2022

Related Announcements

RFA-CA-22-013 - PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform the applicant community of a correction to Funding Opportunity Announcement (FOA) RFA-CA-22-013, PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)

The following section of RFA-CA-22-013 has been corrected:

Part 1. Overview Information

Currently Reads:

Number of Applications

Only one application per institution is allowed as defined in Section III. 3. Additional Information on Eligibility.

Should correctly read:

Number of Applications

See Section III. 3. Additional Information on Eligibility.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Jeffrey A. Moscow, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-6565
Email: [email protected]

Financial/Grants Management Contact(s)

Shane Woodward
National Cancer Institute (NCI)
Telephone: 240-276-6303
Email: [email protected]